3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Gastrointestinal
1
Conditions
Multiple Myeloma
202
Leukemia, Lymphocytic, Chronic, B-Cell
54
Recurrence
37
Neoplasms, Plasma Cell
30
Lymphoma, Mantle-Cell
30
Lymphoma
30
Lymphoma, Follicular
29
Lymphoma, Large B-Cell, Diffuse
27
Leukemia
23
Leukemia, Myeloid, Acute
22
Lymphoma, Non-Hodgkin
21
Lymphoma, B-Cell, Marginal Zone
15
Myelodysplastic Syndromes
13
Hodgkin Disease
12
Waldenstrom Macroglobulinemia
8
Prostatic Neoplasms
8
Lymphoma, T-Cell
8
Smoldering Multiple Myeloma
7
Immunoglobulin Light-chain Amyloidosis
7
Neoplasms
6
Melanoma
6
Lymphoma, B-Cell
6
Hematologic Diseases
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Lymphoma, T-Cell, Cutaneous
5
Lymphoma, Large-Cell, Anaplastic
5
Leukemia, Myelomonocytic, Chronic
5
Hematologic Neoplasms
5
Amyloidosis
5
Sezary Syndrome
4
Interventions
Cetuximab
3
Gemcitabine
2
Gefitinib
2
Biopsy
2
vandetanib
1
temsirolimus
1
ficlatuzumab
1
cediranib
1
X-Rays
1
Soybean Proteins
1
Sirolimus
1
Rhinoplasty
1
Restraint, Physical
1
Radiotherapy, Intensity-Modulated
1
Pilocarpine
1
Pemetrexed
1
Paclitaxel
1
Optical Imaging
1
Nivolumab
1
Methods
1
Metformin
1
Lenalidomide
1
Ipilimumab
1
Independent Medical Evaluation
1
Immunohistochemistry
1
Educational Status
1
Carboplatin
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Lymphoid Interstitial Pneumonia
×
Lenalidomide
×
Clear all
NCT01254617
2020-03-13
ADCC
National Cancer Institute (NCI)
Phase 1
Completed
24 enrolled